Comparison of Outcomes of Immunological High Risk Kidney Transplantation

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20220412002

Enrollment

400

Registered

2022-04-12

Start date

2022-04-30

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

deceased donor kidney transplant recipients, ABO-incompatible living donor kidney transplant recipients and HLA-incompatible living donor kidney transplant recipients in King Chulalongkorn Memorial Hospital Kidney transplant ABO-incompatible HLA-incompatible

Interventions

Patients underwent deceased donor kidney transplants in King Chulalongkorn Memorial Hospital since January 1, 2008 until December 31, 2021,Patients underwent ABO-incompatible living kidney transplants

Treatment,Treatment,Treatment

Deceased donor kidney transplant recipient,ABO-incompatible living kidney transplants,HLA-incompatible living kidney transplants

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years 2. Kidney transplant recipients (deceased donor kidney transplant recipients, ABO-incompatible living donor kidney transplant recipients and HLA-incompatible living donor kidney transplant recipients) in King Chulalongkorn Memorial Hospital since January 1, 2008 until December 31, 2021

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

Measure	Time frame
Patient survival at the end of study months	—

Secondary

Measure	Time frame
Graft survival at the end of study Months	—

Countries

Thailand

Contacts

Public ContactAthiphat Banjongjit

Division of nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University

athiphat_b@hotmail.com0851094113

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026